Bullish Moving Averages
10
Bearish Moving Averages
6
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul
Performance
Today’s low
1623.80Today’s High
1653.2052W low
1132.0052W High
1683.00Open Price
1624.60Prev. Close
1624.6500Volume
1258911.00Value
2065495277.70Fundamentals
Market Cap
132502.20
Price to Earnings
30.80
Price to Book Value
4.90
Dividend Yield
0.80
PE to Growth
0.80
Op Revenue TTM
26139.14
Net Profit TTM
4303.49
Cash From Operating Activity
4133.91
Return on Equity %
15.43
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
08 Oct, 2024
56.5
Week
52.3
Month
54.3
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1639.25
PIVOT
First Resistance
1654.65
Second Resistance
1668.60
Third Resistance
1684.00
First Support
1625.30
Second Support
1609.90
Third Support
1595.95
Relative Strength Index
51.71
Money Flow Index
35.91
MACD
7.81
MACD Signal
12.77
Average True Range
35.3
Average Directional Index
20.81
Rate of Change (21)
1.84
Rate of Change (125)
13.2
Day Commodity Channel Index
-37
William
-37.69
BETA
1 Month
0.53
3 Month
0.72
1 Year
0.29
3 Year
0.09
PRICE CHANGE ANALYSIS
↓ -0.81%
1 Week
Low
High
1577.3
1678
↑ 1.84%
1 Month
Low
High
1577.3
1683
↑ 8.66%
3 Months
Low
High
1470.65
1683
↑ 13.2%
6 Months
Low
High
1317.25
1683
↑ 41.07%
1 Year
Low
High
1132
1683
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 4714.57 | 4575.27 | 4550.31 | 4869.81 | 4476.17 | 4013.45 | 4026.57 | 4243.55 | 3274.81 | 3262.92 | 4027.79 | 4132.76 | 4097.07 | |
| Operating Expenses Qtr | 3141.19 | 3208.77 | 3025.47 | 3285.60 | 3113.50 | 3093.96 | 2961.34 | 3090.22 | 2299.75 | 2558.96 | 2914.81 | 2952.21 | 2871.92 | |
| Operating Profit Qtr | 1359.86 | 827.89 | 1355.86 | 1379.12 | 1204.69 | 799.78 | 938.11 | 1061.05 | 857.38 | 387.65 | 1039.98 | 982.82 | 1145.49 | |
| EBIDT Qtr Cr | 1573.38 | 1422.87 | 1621.22 | 1584.21 | 1362.67 | 733.59 | 1065.23 | 1168.44 | 1090.22 | 880.62 | 1112.98 | 1180.55 | 1225.15 | |
| Depreciation Qtr | 137.86 | 136.81 | 135.02 | 179.81 | 135.95 | 161.58 | 129.96 | 176.01 | 107.46 | 116.82 | 133.95 | 138.97 | 136.98 | |
| Net Profit Qtr | 1055.94 | 1038.40 | 1114.14 | 1029.69 | 895.02 | 355.49 | 678.52 | 720.30 | 759.16 | 652.96 | 730.83 | 782.37 | 791.77 | |
| Basic EPS Qtr | 13.08 | 12.86 | 13.80 | 12.76 | 11.09 | 4.40 | 8.41 | 8.74 | 7.98 | 8.09 | 9.06 | 9.70 | 9.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 17645.00 | 16247.39 | 13758.49 | 14130.86 | 13552.00 | |
| Operating Expenses Annual Cr | 12090.19 | 11998.02 | 9725.32 | 10179.02 | 9951.86 | |
| Operating Profit Annual | 4484.15 | 3792.58 | 3366.47 | 3721.56 | 2707.29 | |
| Operating Profit Margin Annual % | 25.41 | 23.34 | 24.47 | 26.34 | 19.98 | |
| Total Expenses Annual Cr | 12698.03 | 12620.95 | 10212.26 | 10780.20 | 10587.69 | |
| EBIDT Annual Cr | 5554.81 | 4249.37 | 4033.17 | 3951.84 | 3600.14 | |
| EBIDT Annual margin % | 31.48 | 26.15 | 29.31 | 27.97 | 26.57 | |
| Depreciation | 587.59 | 595.91 | 460.01 | 556.11 | 599.78 | |
| PAT Before ExtraOrdinary Items Annual Cr | 3714.19 | 2469.53 | 2689.39 | 2468.28 | 2318.17 | |
| Net Profit Annual | 4077.25 | 2513.47 | 2957.93 | 2468.28 | 2318.17 | |
| Basic EPS Annual | 50.51 | 31.15 | 36.67 | 30.61 | 28.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 27973.92 | 24638.09 | 22513.55 | 19927.56 | 17402.96 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 217.06 | 258.64 | 206.94 | 344.24 | 383.41 | |
| Total Current Liabilities Annual Cr | 2862.25 | 2699.74 | 2728.56 | 2691.94 | 2619.29 | |
| Total Capital Plus Liabilities Annual Cr | 31053.23 | 27596.47 | 25449.05 | 22963.74 | 20405.66 | |
| Fixed Assets Annual | 4388.90 | 4313.25 | 3604.88 | 4421.56 | 4470.71 | |
| Total Non Current Assets Annual | 16146.43 | 14225.34 | 13424.42 | 12771.56 | 11378.60 | |
| Total Current Assets Annual | 14906.80 | 13371.13 | 12024.63 | 10192.18 | 9027.06 | |
| Total Assets Annual | 31053.23 | 27596.47 | 25449.05 | 22963.74 | 20405.66 | |
| Contingent Liabilities plus Commitments Annual Cr | 2298.65 | 897.09 | 975.31 | 1972.95 | 3121.80 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 3726.77 | 3035.05 | 2773.43 | 3460.31 | 2018.14 | |
| Cash from Investing Activity Annual | -2882.82 | -2757.95 | -2463.73 | -3360.45 | -1126.33 | |
| Cash from Financing Annual Activity | -708.83 | -424.77 | -426.72 | -65.80 | -693.89 | |
| Net Cash Flow Annual | 135.12 | -147.67 | -117.02 | 34.06 | 197.92 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 | |
| ROE Annual % | 14.57 | 10.20 | 13.13 | 12.38 | 13.32 | |
| ROCE Annual % | 17.61 | 14.67 | 15.72 | 16.75 | 16.86 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 33.51 | 26.91 | 30.80 | 28.42 | 28.43 |
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 6854.13 | 6412.57 | 6788.44 | 6854.47 | 6465.18 | 5873.93 | 5924.53 | 5951.49 | 5478.62 | 5324.35 | 5570.15 | 5580.47 | 5569.28 | |
| Operating Expenses Qtr | 4978.14 | 4847.38 | 4856.28 | 4944.40 | 4834.98 | 4565.56 | 4402.54 | 4526.21 | 4231.84 | 4510.61 | 4247.89 | 4293.60 | 4158.46 | |
| Operating Profit Qtr | 1715.80 | 1315.86 | 1747.53 | 1733.75 | 1493.91 | 1173.74 | 1407.55 | 1302.33 | 1143.35 | 749.72 | 1230.97 | 1226.20 | 1345.89 | |
| EBIDT Qtr Cr | 1875.99 | 1565.19 | 1737.34 | 1910.07 | 1630.20 | 1125.95 | 1521.99 | 1425.28 | 1246.78 | 756.24 | 1322.26 | 1286.87 | 1286.20 | |
| Depreciation Qtr | 246.68 | 288.34 | 233.43 | 290.04 | 239.21 | 346.22 | 272.11 | 299.37 | 254.41 | 290.31 | 247.47 | 253.06 | 261.11 | |
| Net Profit Qtr | 1177.64 | 939.04 | 1055.90 | 1130.91 | 995.70 | 521.51 | 800.96 | 788.90 | 686.40 | 362.07 | 728.60 | 711.36 | 714.72 | |
| Basic EPS Qtr | 14.58 | 11.63 | 13.08 | 14.01 | 12.34 | 6.51 | 9.92 | 9.78 | 8.51 | 4.49 | 9.03 | 8.82 | 8.86 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 26520.66 | 23228.57 | 22044.25 | 19425.58 | 17476.19 | |
| Operating Expenses Annual Cr | 19483.04 | 17726.15 | 17210.56 | 14907.16 | 13926.00 | |
| Operating Profit Annual | 6291.05 | 5026.97 | 4552.78 | 4252.43 | 3205.99 | |
| Operating Profit Margin Annual % | 23.72 | 21.64 | 20.65 | 21.89 | 18.34 | |
| Total Expenses Annual Cr | 20623.94 | 19007.80 | 18368.86 | 16135.52 | 15298.01 | |
| EBIDT Annual Cr | 7037.62 | 5502.42 | 4833.69 | 4518.42 | 3550.19 | |
| EBIDT Annual margin % | 26.54 | 23.69 | 21.93 | 23.26 | 20.31 | |
| Depreciation | 1051.02 | 1172.11 | 1051.95 | 1067.66 | 1174.65 | |
| PAT Before ExtraOrdinary Items Annual Cr | 4155.31 | 2835.49 | 2559.47 | 2401.30 | 1546.98 | |
| Net Profit Annual | 4121.55 | 2801.91 | 2516.75 | 2404.87 | 1546.52 | |
| Basic EPS Annual | 51.01 | 34.69 | 31.17 | 29.79 | 19.16 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 26706.43 | 23407.78 | 20841.69 | 18326.53 | 15763.00 | |
| Minority Interest Liability Annual Cr | 95.90 | 305.76 | 275.69 | 259.06 | 294.28 | |
| Total Non Current Liabilities Annual Cr | 669.72 | 640.07 | 1070.53 | 1974.75 | 3212.14 | |
| Total Current Liabilities Annual Cr | 5245.77 | 5109.67 | 4913.21 | 4591.55 | 4393.14 | |
| Total Capital Plus Liabilities Annual Cr | 32717.82 | 29463.28 | 27101.12 | 25151.89 | 23662.56 | |
| Fixed Assets Annual | 7647.90 | 7269.92 | 7311.58 | 7477.12 | 7573.42 | |
| Total Non Current Assets Annual | 13276.41 | 12188.33 | 12373.58 | 11942.38 | 11956.38 | |
| Total Current Assets Annual | 19441.41 | 17274.95 | 14727.54 | 13209.51 | 11706.18 | |
| Total Assets Annual | 32717.82 | 29463.28 | 27101.12 | 25151.89 | 23662.56 | |
| Contingent Liabilities plus Commitments Annual Cr | 4629.56 | 1095.87 | 1291.24 | 1178.42 | 1382.19 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 4133.91 | 3237.65 | 3325.90 | 3755.20 | 3068.45 | |
| Cash from Investing Activity Annual | -2988.03 | -2388.51 | -1871.88 | -2387.18 | 104.04 | |
| Cash from Financing Annual Activity | -1200.43 | -958.29 | -1599.79 | -1329.90 | -2948.82 | |
| Net Cash Flow Annual | -54.55 | -109.15 | -145.77 | 38.12 | 223.67 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 331.98 | 293.79 | 261.74 | 230.46 | 199.16 | |
| ROE Annual % | 15.43 | 11.96 | 12.07 | 13.12 | 9.81 | |
| ROCE Annual % | 21.79 | 17.78 | 17.04 | 16.78 | 12.32 | |
| Total Debt to Total Equity Annual | 0.01 | 0.02 | 0.04 | 0.08 | 0.18 | |
| EBDIT Annual Margin % | 27.30 | 24.18 | 22.21 | 23.58 | 20.72 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| HDFC MUTUAL FUND - HDFC FOCUSED 30 FUND | 4.94 | 89037959 | - | - |
| SBI LONG TERM EQUITY FUND | 3.24 | 89037960 | - | - |
| ICICI PRUDENTIAL S&P BSE 500 ETF | 1.12 | 89037961 | - | - |
| GOVERNMENT PENSION FUND GLOBAL | 2.08 | 89037971 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SOPHIE AHMED | 5.7 | 89037942 | 0 | 0 |
| M K HAMIED | 3.45 | 89037943 | 0 | 0 |
| SAMINA HAMIED | 1.11 | 89037944 | 0 | 0 |
| RUMANA HAMIED | 0.61 | 89037945 | 0 | 0 |
| Yusuf Khwaja Hameid | 18.67 | 89037954 | 0 | 0 |
| Kamil Hamied | 1.36 | 89037955 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HDFC MUTUAL FUND - HDFC FOCUSED 30 FUND | 4.94 | 89037959 |
| SBI LONG TERM EQUITY FUND | 3.24 | 89037960 |
| ICICI PRUDENTIAL S&P BSE 500 ETF | 1.12 | 89037961 |
| UTI NIFTY INDEX FUND | 1.01 | 89037962 |
| GOVERNMENT PENSION FUND GLOBAL | 2.08 | 89037971 |
| LIC | 3.53 | 89037964 |
| NPS | 1.58 | 89037966 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 02, 2024 | 13 | FINAL | Aug 02, 2024 | Equity Share |
| Jul 21, 2023 | 8.5 | FINAL | Jul 21, 2023 | Equity Share |
| Aug 08, 2022 | 5 | FINAL | Aug 10, 2022 | Equity Share |
| Aug 09, 2021 | 5 | FINAL | - | Equity Share |
| Mar 19, 2020 | 1 | SPECIAL | Mar 20, 2020 | Equity Share |
| Mar 19, 2020 | 3 | INTERIM | Mar 20, 2020 | Equity Share |
| Jul 31, 2019 | 3 | FINAL | - | Equity Share |
| Aug 13, 2018 | 3 | FINAL | - | Equity Share |
| Jul 26, 2017 | 2 | FINAL | - | Equity Share |
| Sep 12, 2016 | 2 | FINAL | - | Equity Share |
| Aug 11, 2015 | 2 | FINAL | - | Equity Share |
| Aug 06, 2014 | 2 | FINAL | - | Equity Share |
| Aug 06, 2013 | 2 | FINAL | - | Equity Share |
| Aug 01, 2012 | 2 | FINAL | - | Equity Share |
| Aug 09, 2011 | 2 | FINAL | - | Equity Share |
| Sep 03, 2010 | 0.8 | INTERIM | Sep 06, 2010 | Equity Share |
| Jul 23, 2010 | 2 | FINAL | - | Equity Share |
| Aug 10, 2009 | 2 | FINAL | - | Equity Share |
| Aug 12, 2008 | 2 | FINAL | - | Equity Share |
| Aug 08, 2007 | 2 | FINAL | - | Equity Share |
| Aug 18, 2006 | 2 | FINAL | - | Equity Share |
| Aug 19, 2005 | 3.5 | FINAL | - | Equity Share |
| Aug 19, 2004 | 3 | FINAL | - | Equity Share |
| Aug 22, 2003 | 10 | FINAL | - | Equity Share |
| Aug 14, 2002 | - | FINAL | - | Equity Share |
| Aug 06, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| May 11, 2004 | 10:2 | 2004-05-19 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| Oct 29, 2024 | Quarterly Results | - |
| Jul 26, 2024 | Quarterly Results | - |
| May 10, 2024 | Audited Results & Final Dividend | - |
| Jan 22, 2024 | Quarterly Results | (Revised) |
| Oct 27, 2023 | Quarterly Results | - |
| Jul 26, 2023 | Quarterly Results | - |
| May 12, 2023 | Audited Results & Final Dividend | - |
| Jan 25, 2023 | Quarterly Results | - |
| Nov 04, 2022 | Quarterly Results | - |
| Jul 29, 2022 | Quarterly Results | - |
| May 10, 2022 | Audited Results & Dividend | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 26, 2021 | Quarterly Results | - |
| Aug 05, 2021 | Quarterly Results | - |
| May 14, 2021 | Audited Results & Dividend | - |
| Jan 29, 2021 | Quarterly Results | - |
| Nov 06, 2020 | Quarterly Results | - |
| Aug 07, 2020 | Quarterly Results | - |
| May 15, 2020 | Audited Results & Others | Inter-alia to Obtain an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Mar 12, 2020 | Interim Dividend | - |
| Feb 05, 2020 | Quarterly Results | - |
| Nov 06, 2019 | Quarterly Results | - |
| Aug 07, 2019 | Quarterly Results | - |
| May 22, 2019 | Others | inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Feb 06, 2019 | Quarterly Results | - |
| Nov 05, 2018 | Quarterly Results | - |
| Aug 08, 2018 | Quarterly Results | - |
| May 22, 2018 | Audited Results, Dividend & Others | Inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Feb 07, 2018 | Quarterly Results | - |
| Nov 07, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 25, 2017 | Audited Results & Dividend | - |
| Feb 08, 2017 | Quarterly Results | - |
| Dec 19, 2016 | Issue of Equity Shares | - |
| Nov 09, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| Jun 08, 2016 | Appointment of CFO | - |
| May 24, 2016 | Audited Results & Dividend | Recommended the appointment of Walker Chandiok & Co LLP, Chartered Accountants, as statutory auditors of the Company. |
| Feb 10, 2016 | Quarterly Results | - |
| Nov 05, 2015 | Quarterly Results | Re-appointed Mr. S. Radhakrishnan as a Whole-time Director for a term of two years with effect from November 12, 2015. |
| Aug 14, 2015 | Quarterly Results | - |
| Jul 09, 2015 | Appointment of Directors | - |
| May 29, 2015 | Audited Results & Dividend | - |
| Feb 12, 2015 | Quarterly Results | - |
| Nov 13, 2014 | Quarterly Results | - |
| Aug 14, 2014 | Quarterly Results | - |
| May 29, 2014 | Audited Results & Dividend | - |
| Feb 12, 2014 | Quarterly Results | - |
| Nov 13, 2013 | Quarterly Results | - |
| Aug 09, 2013 | Quarterly Results | - |
| May 29, 2013 | Audited Results & Dividend | - |
| Feb 06, 2013 | Quarterly Results | - |
| Nov 05, 2012 | Quarterly Results | - |
| Jul 31, 2012 | Quarterly Results | - |
| Jun 07, 2012 | Audited Results & Dividend | - |
| May 10, 2012 | Quarterly Results | - |
| Feb 13, 2012 | Quarterly Results | - |
| Nov 14, 2011 | Quarterly Results | - |
| Aug 05, 2011 | Quarterly Results | - |
| Jun 29, 2011 | Audited Results & Dividend | - |
| May 05, 2011 | Quarterly Results | - |
| Feb 04, 2011 | Quarterly Results | - |
| Nov 11, 2010 | Quarterly Results | - |
| Aug 25, 2010 | Special Interim Dividend & Others | To consider special interim dividend for the FY 2010-2011 & to approve the acquisition of Meditab Specialities Pvt. Ltd. for an aggregate consideration of Rs. 133.35 Crs. |
| Aug 13, 2010 | Quarterly Results | - |
| Jun 15, 2010 | Audited Results, Dividend & Others | For acquisition of 40% stake in a biotech Co. based in India through subscription of fresh Shares & 25% stake in a biotech Co. in Hong Kong through subscription of fresh Shares of the Company. |
| May 07, 2010 | Quarterly Results & Others | For acquisition of two manufacturing facilities which hitherto were manufacturing formulations and bulk drugs / intermediates exclusively for Cipla Ltd. for an aggregate consideration of Rs. 82.02 Cr. |
| Jan 28, 2010 | Quarterly Results | - |
| Oct 28, 2009 | Quarterly Results | - |
| Jul 29, 2009 | Quarterly Results & Others | To raise funds upto Rs 1500 Crs by further issue of securities in domestic / international markets through various instruments including equity shares / warrants with NCD's under QIPs / FCCBs & etc. |
| Jul 15, 2009 | Audited Results & Dividend | - |
| Apr 24, 2009 | Quarterly Results | - |
| Jan 22, 2009 | Quarterly Results | - |
| Oct 22, 2008 | Quarterly Results | - |
| Jul 18, 2008 | Audited, Quarterly Results & Dividend | - |
| Apr 25, 2008 | Quarterly Results | - |
| Jan 24, 2008 | Quarterly Results | - |
| Oct 24, 2007 | Quarterly Results | - |
| Jul 20, 2007 | Audited Results, Dividend & Qtr Results | - |
| Apr 26, 2007 | Quarterly Results | - |
| Jan 23, 2007 | Quarterly Results | - |
| Oct 20, 2006 | Quarterly Results | - |
| Jul 21, 2006 | Accounts, Dividend & Qtr Results | - |
| Apr 25, 2006 | Quarterly Results | - |
| Feb 11, 2006 | Bonus Issue & Issue of securities | Increase in the limit of investment by Foreign Institutional Investors into the paid-up capital / securities of the Company. |
| Jan 24, 2006 | Quarterly Results | - |
| Oct 27, 2005 | Quarterly Results | - |
| Jul 25, 2005 | Accounts, Dividend & Quarterly Results | - |
| Apr 26, 2005 | Quarterly Results | - |
| Jan 18, 2005 | Quarterly Results | - |
| Oct 26, 2004 | Quarterly Results | - |
| Jul 23, 2004 | Quarterly Results & Dividend | - |
| Apr 21, 2004 | Quarterly Results | - |
| Mar 23, 2004 | Stock Split | - |
| Jan 30, 2004 | Quarterly Results | - |
| Oct 31, 2003 | Quarterly Results | - |
| Jul 28, 2003 | Dividend & Quarterly Results | - |
| Apr 25, 2003 | Quarterly Results | - |
| Jan 18, 2003 | Quarterly Results | - |
| Oct 22, 2002 | Quarterly Results | - |
| Jul 24, 2002 | Accounts & Dividend | - |
| Apr 29, 2002 | Quarterly Results | - |
| Mar 04, 2002 | Interim Dividend | - |
| Jan 19, 2002 | Quarterly Results | - |
| Oct 20, 2001 | Quarterly Results | - |
| Jul 26, 2001 | Accounts, Dividend & Quarterly Results | - |
| Apr 26, 2001 | Quarterly Results | - |
| Jan 30, 2001 | Quarterly Results | - |
| Oct 24, 2000 | Quarterly Results | - |
| Jul 26, 2000 | Quarterly Results | - |
| Apr 27, 2000 | Quarterly Results | - |
| Mar 22, 2000 | Interim Dividend | - |
| Aug 06, 1999 | Bonus Issue | - |
| Jul 22, 1999 | Accounts, Dividend & Quarterly Results | - |
| Jan 28, 1999 | Quarterly Results | - |
| Oct 29, 1998 | Quarterly Results | - |
| Nov 14, 1997 | Half Yearly Results | - |
| Jul 24, 1997 | Accounts & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Apr 24, 2006 | 3:2 | 2006-04-25 |
05 Oct 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 5th October, 2024 has allotted 28,465 equity shares of INR 2 each, pursuant to exercise of employee stock options/stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.
01 Oct 2024
CIPLA LTD. - 500087 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 (''Listing Regulations'')
CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2024.
25 Sep 2024
Cipla To Buy Out Local Partner's Stake In Chinese Subsidiary For Over Rs 42 Crore
Cipla Jiangsu was incorporated in China in Aug. 2019 as a joint venture between Cipla (EU) and Xidi.
25 Sep 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation under Regulation 30 read with Schedule lll of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
14 Sep 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for Notice of Postal Ballot and e-voting information
13 Sep 2024
CIPLA LTD. - 500087 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot dated 3rd September 2024
12 Sep 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
In compliance with the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 12th September, 2024 has allotted 7,059 fully paid up equity shares of the INR 2 each pursuant to exercise of employee stock options/ stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.
04 Sep 2024
Change at Cipla, as MK Hamied resigns and son Kamil re-enters the drugmaker
The developments involving Cipla's promoter family come even as reports suggested, as recently as last year, that members of the promoter family were looking to sell their stake
04 Sep 2024
CIPLA LTD. - 500087 - Corrigendum - Outcome Of Board Meeting Held On 3Rd September 2024
Corrigendum - Outcome of Board meeting held on 3rd September 2024
03 Sep 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Change in Directorate
Change in Directors of the Company
